Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in

In a recent bioRxiv paper, a research group from the Marinomed Biotech biopharmaceutical company in Austria showed that a sulfated polysaccharide iota-carrageenan has the propensity to inhibit cell entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using an in vitro neutralization assay.

Biological Activities of Carrageenan from Red Algae: a Mini Review

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

Cuáles son algunas adaptaciones de las algas?

The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review - Clinical Epidemiology and Global Health

SARS-CoV-2 in the Environment: Its Transmission, Mitigation, and Prospective Strategies of Safety and Sustainability

Nutraceuticals, Free Full-Text

Antiviral activity of sulfated polysaccharides from marine algae and its application in combating COVID-19: Mini review - ScienceDirect

Frontiers Carrageenan From Kappaphycus alvarezii (Rhodophyta, Solieriaceae): Metabolism, Structure, Production, and Application

Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2

PDF) Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta

Full article: The vital role of animal, marine, and microbial natural products against COVID-19

Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture